PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 20261 citations

Concerns on methodological assumptions in the health economic Evaluation of return-to-work interventions.

View Full Paper
AGAfschin Gandjour

Key Points

  • This evaluation scrutinizes the assumptions made in evaluating the economic impacts of return-to-work interventions.
  • Examined a modeling study comparing inpatient multimodal occupational rehabilitation and outpatient Acceptance and Commitment Therapy.
  • Linked a randomized trial to seven years of registry follow-up.
  • Projected costs and effects over a 25-year horizon from healthcare and societal perspectives.
  • Found that the lifetime dominance of I-MORE relies on specific structural assumptions.
  • Productivity gains are maintained even after certain state prevalences equalize.
  • The incremental cost-effectiveness ratio for healthcare alone is deemed unfavorable.

Abstract

This Key Paper Evaluation examines a recent modeling study of return-to-work (RTW) interventions comparing inpatient multimodal occupational rehabilitation (I-MORE) with outpatient Acceptance and Commitment Therapy (ACT). The authors link a randomized trial to seven years of registry follow-up and project costs and effects over a 25-year horizon from healthcare and societal perspectives. We commend the clear intervention definitions, transparent multistate-to-Markov approach, and probabilistic analyses. However, the study's headline finding - lifetime dominance of I-MORE when productivity is counted - hinges on structural assumptions: transition intensities are frozen beyond four years, and within-state absence-day differences are held constant thereafter, generating persistent productivity gains even after state prevalences converge. Health-related quality of life is observed only to 14 months and then modeled as state-specific constants, compressing incremental quality-adjusted life years and leaving the healthcare-only incremental cost-effectiveness ratio unfavorable. We argue that lifetime savings should be treated as upper-bound estimates and that decision relevance would be strengthened by waning-effect scenarios, mid-term horizons, and tests of the absorbing disability state. We also highlight the need for diagnosis-by-treatment analyses and stepped-care sequences given the heterogeneous population and fixed-dose ACT comparator. Overall, the paper advances RTW modeling while underscoring how perspective and structure shape long-run conclusions.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Afschin Gandjour (2026) studied this question.

synapsesocial.com/papers/698827a20fc35cd7a8846783https://doi.org/10.1080/14737167.2026.2629352
Ask AI
Helpful
Bookmark
Share
View Full Paper